iBio, Inc.
IBIO· Nasdaq
IBIOiBio, Inc.
Filed Oct 12, 2012 · 10-K · 104 days after period end · 0000930413-12-005714
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|
| Revenue | $351.07K | — |
| Net Income | -$1.36M | -$1.58M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Oct 12, 2012 · 104 d after period end
